Dataset Information
A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial.
Ontology highlight
ABSTRACT:
SUBMITTER: Bosaeed M
PROVIDER: S-EPMC7602769 | biostudies-literature | 2020 Oct
REPOSITORIES: biostudies-literature
Publications
A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial.
Trials 20201031 1
<h4>Objectives</h4>The selected combination was based on limited evidence clinically and in vitro on the efficacy of the Favipiravir and Hydroxychloroquine in SARS-CoV-2. The two medications were listed in many guidelines as treatment options and ongoing trials assessing their efficacy and safety. Thus, we want to prove the clinical effectiveness of the combination as therapy.<h4>Trial design</h4>This is an Open label, multicenter, randomized controlled clinical trial to evaluate the safety and ...[more]